Jim Simons Renaissance Technologies
AUM
$75.8B
1-Year Est. Return
50.56%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
1 Year Est. Return
+50.56%
AUM
$75.8B
AUM Growth
+$582M
(+0.77%)
Holding
4,038
Top Buys
| 1 | +$633M | |
| 2 | +$487M | |
| 3 | +$419M | |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Coca-Cola
KO
|
+$257M |
Top Sells
| 1 | +$1.36B | |
| 2 | +$900M | |
| 3 | +$583M | |
| 4 |
NVIDIA
NVDA
|
+$335M |
| 5 |
Netflix
NFLX
|
+$320M |
Sector Composition
| 1 | Technology | 21.72% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.8% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
DNOW Inc
DNOW
$2.56B
| $57.8M | 0.08% |
3,788,914
+93,200
|
|
||
302
Pinterest
PINS
$18.3B
| $57.7M | 0.08% |
1,794,871
-643,915
|
|
||
303
PTC Therapeutics
PTCT
$6.17B
| $56.9M | 0.08% |
927,300
-36,000
|
|
||
304
Johnson & Johnson
JNJ
$486B
| $56.9M | 0.08% |
306,747
-576,443
|
|
||
305
DexCom
DXCM
$25.6B
| $56.6M | 0.07% |
841,564
+143,762
|
|
||
306
EPR Properties
EPR
$3.87B
| $56.6M | 0.07% |
975,823
-601,794
|
|
||
307
Takeda Pharmaceutical
TAK
$44.9B
| $56.6M | 0.07% |
3,864,600
+565,400
|
|
||
308
NIO
NIO
$12.8B
| $56.5M | 0.07% |
7,413,440
-876,000
|
|
||
309
Herbalife
HLF
$1.22B
| $56.5M | 0.07% |
6,688,468
-215,600
|
|
||
310
WD-40
WDFC
$2.54B
| $56.4M | 0.07% |
285,561
+7,300
|
|
||
311
Veeva Systems
VEEV
$39.3B
| $56M | 0.07% |
188,000
-324,600
|
|
||
312
Collegium Pharmaceutical
COLL
$1.51B
| $56M | 0.07% |
1,599,189
+78,019
|
|
||
313
FirstEnergy
FE
$25.9B
| $55.9M | 0.07% |
1,220,808
+302,608
|
|
||
314
Watsco Inc
WSO
$13.8B
| $55.9M | 0.07% |
138,200
+89,500
|
|
||
315
D-Wave Quantum
QBTS
$10.2B
| $55.7M | 0.07% |
2,253,542
-1,537,800
|
|
||
316
Intercontinental Exchange
ICE
$89.5B
| $55.4M | 0.07% |
328,839
+68,717
|
|
||
317
Madrigal Pharmaceuticals
MDGL
$12.9B
| $55.4M | 0.07% |
120,682
+109,846
|
|
||
318
Trade Desk
TTD
$19B
| $55.3M | 0.07% |
1,127,600
+1,022,046
|
|
||
319
iShares 0-5 Year TIPS Bond ETF
STIP
$12.7B
| $55.2M | 0.07% |
534,400
-77,700
|
|
||
320
Rhythm Pharmaceuticals
RYTM
$7.02B
| $55.2M | 0.07% |
546,593
+231,700
|
|
||
321
LegalZoom.com
LZ
$1.69B
| $55.1M | 0.07% |
5,309,955
+307,805
|
|
||
322
Pacira BioSciences
PCRX
$1.05B
| $55.1M | 0.07% |
2,138,201
-257,400
|
|
||
323
IDT Corp
IDT
$1.2B
| $55.1M | 0.07% |
1,052,506
-47,333
|
|
||
324
CommScope
COMM
$4.38B
| $55M | 0.07% |
3,550,900
-220,100
|
|
||
325
Heidrick & Struggles
HSII
$1.23B
| $54.6M | 0.07% |
1,096,340
-5,400
|
|